U.S. Wireless Telecom Stock News

Warner Bros. Discovery (NasdaqGS:WBD) has agreed to be acquired by Paramount Skydance in a cash and stock deal valued at $110b. The transaction includes a record-breaking golden parachute package for CEO David Zaslav as part of the change in control. The deal follows a period of awards recognition for Warner Bros.' recent film slate and is expected to reshape competition among major studios. For investors tracking NasdaqGS:WBD, this $110b agreement comes after a very strong 1 year share...

Linde plans to build a new industrial gases facility in Oshkosh, Wisconsin. The project is intended to expand supply capacity for industrial customers across the Midwest. The development marks a further investment in regional infrastructure for NasdaqGS:LIN. Linde, trading on NasdaqGS:LIN, is moving ahead with construction of a new industrial gases facility in Oshkosh, Wisconsin, adding to its US footprint. The company’s shares most recently closed at $488.15, with a return of 13.8% year to...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...

Why Sportradar’s latest earnings and deal activity matter for investors Sportradar Group (SRAD) recently reported 2025 earnings, with revenue up 17% to €1,290 million, supported by US growth and a 109% customer net retention rate. The company also closed the IMG ARENA acquisition. The company extended its exclusive data partnership with MLB for 8 years and added new rights with FIFA and the German DFB Cup, expanding coverage to more than 1 million sporting events each year. See our latest...

RCI Hospitality Holdings (RICK) FY 2025 earnings at a glance RCI Hospitality Holdings (RICK) has just posted its FY 2025 numbers with Q4 revenue of US$70.9 million and a basic EPS loss of US$0.63, set against trailing 12 month EPS of US$1.23 on revenue of US$279.4 million and earnings growth of 259.1% for the period. Over recent quarters, revenue has moved from US$73.2 million in Q4 2024 to US$71.5 million in Q1 2025, US$65.9 million in Q2, US$71.1 million in Q3 and US$70.9 million in Q4,...

If you are wondering whether Northern Oil and Gas at around US$28.84 is offering fair value or a potential mismatch between price and underlying worth, you are not alone. The stock has recent returns of 4.8% over 7 days, 5.4% over 30 days, 31.0% year to date and 2.4% over 1 year, which naturally raises questions about how much is already reflected in the price. Recent coverage has focused on Northern Oil and Gas in the context of its role within the broader energy sector and its position as...

In March 2026, Soleno Therapeutics updated its corporate bylaws, continued outreach with a CEO presentation at the Longwood Healthcare Leaders conference, and faced an investor class action lawsuit alleging inadequate disclosure of safety concerns around its Prader‑Willi syndrome therapy DCCR/Vykat XR. This combination of governance changes, legal scrutiny and discussion of a slower Vykat XR launch puts renewed focus on how safety perceptions and patient adoption may shape Soleno’s...

Microvast Holdings (MVST) is back in focus after reaffirming and expanding its long running battery partnership with Iveco Group in Europe, alongside releasing 2025 results, 2026 guidance, and an auditor warning on going concern risks. See our latest analysis for Microvast Holdings. Despite a series of material updates including the expanded Iveco partnership, 2025 results, 2026 guidance and the going concern warning, Microvast’s recent share price performance has been weak. The 30 day share...

If you are wondering whether Viridian Therapeutics at around US$26.98 is offering good value or asking too much, you are in the right place. The stock has recently seen mixed returns, with a 7 day move of 5.9% decline and a 30 day return of 4.0% decline, while still sitting on a 76.8% gain over the past year and 12.1% decline year to date. Recent news coverage has focused on Viridian Therapeutics as a biotech name that continues to attract attention from investors watching the sector. This...

AOP Health’s decision to run its rare disease and intensive care operations on Veeva Systems (VEEV) cloud platforms highlights how deeply Veeva’s software can be embedded across clinical, regulatory, safety, and commercial workflows. See our latest analysis for Veeva Systems. Even with news like the AOP Health rollout highlighting real world use of its platforms, Veeva’s share price tells a mixed story. A 7 day share price return of 2.9% is set against a 1 year total shareholder return...

In recent weeks, oil prices have climbed sharply following the Iran conflict, pushing Brent crude above US$100 per barrel and refocusing attention on efficient US producers such as EOG Resources. The key angle for investors is how EOG’s reputation for low-cost, high-productivity wells may allow it to convert higher prices into additional excess cash to reinvest and return to shareholders. We’ll now examine how this period of elevated oil prices could influence EOG Resources’ existing...

TransMedics Group (TMDX) is drawing attention after a recent share pullback, with reports of insider selling by senior executives and directors coinciding with continued pressure on the stock, despite generally supportive analyst commentary. See our latest analysis for TransMedics Group. The recent weakness in TransMedics Group’s share price, including a 14.28% 1 month share price return decline and a 7.16% negative year to date share price return, sits against a much stronger 64.95% 1 year...

GE Vernova and Hitachi have been selected to supply BWRX-300 small modular reactors for a new US Japan nuclear program. The reactors are planned for deployment in Tennessee and Alabama as part of a wider $40b bilateral investment initiative. The selection positions GE Vernova at the center of a high profile cross border nuclear buildout focused on SMR technology. For investors watching NYSE:GEV, this project ties the company’s nuclear capabilities to a sizeable capital program that goes...

Wondering whether Hewlett Packard Enterprise at around US$21.69 is offering genuine value or just headline appeal? This article breaks down what the current price might be implying about the business. The stock has recent returns of 0.5% over 7 days and 0.6% over 30 days, set against a year to date return of a 10.3% decline, and gains of 37.7% over 1 year, 64.4% over 3 years and 55.8% over 5 years. Recent coverage of Hewlett Packard Enterprise has focused on how investors are reassessing...

Wondering whether Bob's Discount Furniture is a bargain or a value trap at around US$12.49? This article breaks down what the current price might be implying about the business. The stock has seen sharp recent moves, with a 7 day return of an 18.9% decline and a 30 day return of a 37.2% decline, while the year to date return sits at a 26.6% decline. These swings have put Bob's Discount Furniture back on the radar for investors who are reassessing what they are willing to pay for retailers...

If you are wondering whether Copart's share price around US$32.86 is starting to look appealing or still has more room to fall, you are not alone. The stock has seen a 3.6% decline over the last week, a 12.7% decline over the past month, and a 13.0% decline year to date, adding to a 38.7% decline over the past year that may be changing how investors view its potential and risk. Recent coverage has focused on Copart's share price performance and how current levels compare with longer term...

Earlier this month, SailPoint reported fourth-quarter 2026 revenue of US$294.65 million and a net loss of US$36.22 million, alongside full-year revenue of US$1.07 billion and a net loss of US$270.05 million. Ahead of this earnings release, SailPoint expanded its AI-focused identity security platform with new Shadow AI Remediation capabilities and a multi-year collaboration agreement with Amazon Web Services to become a preferred identity governance layer for AI workloads. We’ll now examine...

To understand whether Element Solutions might still offer value at its recent price, you need to see how its fundamentals compare with what the market is currently paying. Over shorter periods, the stock has been mixed, with a 0.2% return over the last week, a 7.9% decline over the last month, a 19.7% gain year to date and a 24.5% return over the last year, alongside 75.2% and 78.7% returns across the past 3 and 5 years respectively. Recent news flow has highlighted Element Solutions in the...

Rexford Industrial Realty stock performance snapshot Rexford Industrial Realty (REXR) has drawn attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year as investors reassess industrial REIT exposure. See our latest analysis for Rexford Industrial Realty. With the latest share price at US$33.97, Rexford Industrial Realty’s recent 30 day share price return of 8.73% decline and 90 day share price return of...

If you are wondering whether LeMaitre Vascular at around US$106 a share still offers value, you are not alone. A closer look at what that price really reflects can be useful. The stock has returned 17.3% over the last 30 days, 32.6% year to date and 28.5% over the past year, which may signal that expectations and perceived risk are shifting. Recent attention on LeMaitre Vascular has centered on how the company is positioned within medical devices and vascular care solutions, as investors...

Textron (NYSE:TXT) has emerged as a key supplier of autonomous mine countermeasure systems for operations in the Strait of Hormuz. The company is supplying unmanned mine clearing technology as maritime security concerns in the region increase. This defense contract activity adds a new driver tied to naval and maritime security demand, separate from prior aviation and helicopter orders. For investors tracking NYSE:TXT, this shift into autonomous mine countermeasure systems comes with the...

DHT Holdings (DHT) has wrapped up FY 2025 with fourth quarter revenue of US$144.2 million and basic EPS of US$0.41, while trailing twelve month figures sit at US$551.3 million of revenue and EPS of US$1.31, underpinned by earnings growth of 16.4% over the last year. Over recent periods, quarterly revenue has moved between US$123.0 million and US$145.8 million, with basic EPS ranging from US$0.22 to US$0.41. Trailing net profit margin has improved from 31.7% to 38.3%, setting the stage for...

ESCO Technologies (ESE) has drawn investor attention after recent share price moves, with the stock down 3% over the past month but up about 31% in the past 3 months. See our latest analysis for ESCO Technologies. At a share price of US$260.95, ESCO Technologies has recently given back some ground, with a 30 day share price return of 3.36% and a 7 day share price return showing a 1.09% decline. However, the 90 day share price return of 31.28% alongside a 1 year total shareholder return of...